16 jul: USA/tendens: Citigroup vil fortsætte positiv bankstime
16 jul: IMF: Nedjusterer vækstforventninger over hele linien
16-07-2012 15:21:00

RBS Stops Submissions To Singapore Interbank Panel

Relateret indhold

By Max Colchester

LONDON--Royal Bank of Scotland Group PLC (RBS) said Monday that it stopped submitting data to Singapore's interbank lending panel, the latest bank to reconsider its role in a rate-setting mechanism that is under increased global regulatory scrutiny.

The decision came as the 82%-U.K. government-owned bank reviews its markets business in Asia and authorities across the globe conduct probes into allegations of interbank rate fixing. The bank said in a statement that it had come to this decision "during the course of its review."

In November last year, RBS dismissed Singapore-based trader Tan Chi Min for attempts to "improperly influence the rate setters" who made the bank's yen Libor submissions, according to a disciplinary letter filed by the employee in a Singapore court. Tan is suing RBS for wrongful termination and alleges that it was "common practice" for top bank employees to ask Libor setters for a certain interest rate, according to the court documents. RBS has already said it would stop contributing to Tibor, the Tokyo Interbank Offered Rate.

Regulators in countries including the U.S. and Japan are probing various financial institutions over alleged manipulation of key benchmark interbank rates, notably the London interbank offered rate, or Libor.

The probe has spurred several banks to withdraw from the panels that set the rates. For instance, Barclays PLC (BCS), is set to withdraw from a panel that sets base interbank interest rates in the United Arab Emirates, according to people familiar with the matter.

Barclays is one of four international banks on a 12-lender panel that determines the U.A.E. central bank's official Emirates Interbank Offered Rate, or Eibor.

Barclays sent a letter to the central bank asking to withdraw from the panel voluntarily, one of the people said. The bank recently paid around $450 million to settle with U.K. and U.S. authorities over allegation that traders at the bank sought to pad the bank's profits and make the banks funding position look stronger by submitting false borrowing data.

-Write to Max Colchester at max.colchester@wsj.com

(Sam Holmes contributed to this article.)

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

(END) Dow Jones Newswires

July 16, 2012 09:21 ET (13:21 GMT)

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

DSV/Nykredit: Kursmål bliver hævet med 8 pct. før regnskab

28-04-2017 14:21:41
Nykredit hæver kursmålet for DSV-aktien til 400 kr. fra 370 kr. forud for transportkoncernens regnskab i næste uge.Banken vurderer, at DSV står stærkt på markedet og kan begynde at fokusere på organisk vækst, efter at det seneste år primært er gået med at integrere amerikanske UTI Worldwide, der blev købt sidste år for 9,5 mia. kr.- Vi har hævet vores estimater for de kommende år. Derudover har vi..

Novo/Nordea: Sanofi-regnskab indikerer lyspunkt på vækstmarkeder

28-04-2017 11:31:07
Kvartalsregnskabet fra Novo Nordisks store franske rival, Sanofi, vidner om, at diabetesforretningen har haft en en stærk udvikling på vækstmarkederne, mens salget er under pres i USA.Og det er en tendens, som Nordea regner med også kan slå igennem i Novos regnskabstal på onsdag. Det fremgår af et notat.Nordea understreger dog, at det langt fra er ligetil at drage paralleller fra Sanofis regnskab...

Novo-rival slår overskuds- og salgsforventninger i første kvartal - NY

28-04-2017 08:06:11
Den franske medicinalvirksomhed Sanofi, der er blandt Novo Nordisks største konkurrenter, er kommet ud af årets første tre måneder med en bedre indtjening end ventet.I første kvartal endte det justerede overskud per aktie (Business EPS, red.) på 1,42 euro, hvilket var højere end de 1,26 euro, som analytikerne ifølge Bloomberg News havde sat næsen op efter.Den samlede omsætning steg til 8,65 mia. e..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge

Relaterede aktiekurser

Barclays PLC ORD 25P 212,02 -5,3% Fald i aktiekurs
Royal Bank of Scotland G.. 265,14 4,6% Stigning i aktiekurs
Barclays PLC 10,81 -6,1% Fald i aktiekurs
Royal Bank of Scotland G.. 6,84 4,6% Stigning i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
30. april 2017 14:51:57
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseCandidateBuild_20170427.1 - EUROWEB7 - 2017-04-30 14:51:57 - 2017-04-30 14:51:57 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x